Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.45
-0.05 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
7.38
-0.07 (-0.94%)
After-hours: Apr 28, 2026, 7:49 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $733.04 million as of April 28, 2026. Its market cap has increased by 254.30% in one year.
Market Cap
733.04M
Enterprise Value
566.35M
1-Year Change
254.30%
Ranking
Category
Stock Price
$7.45
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $733.04M, a decrease of -2.79%. That is a compound annual growth rate of -0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 737.90M | 67.93% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 790.02M |
| ARS Pharmaceuticals | 789.41M |
| Allogene Therapeutics | 773.95M |
| Vor Biopharma | 765.10M |
| Tenax Therapeutics | 760.04M |
| Absci | 742.15M |
| Relmada Therapeutics | 737.36M |
| Lexicon Pharmaceuticals | 716.02M |